Navigation Links
Innovative Clinical Solutions, Ltd. Announces Second and Final Liquidating Cash Distribution
Date:12/13/2010

PHILADELPHIA, Dec. 13, 2010 /PRNewswire-FirstCall/ -- Innovative Clinical Solutions, Ltd. (Pink Sheets: ICSN) has announced that, in accordance with its plan of liquidation approved by its shareholders on September 22, 2007, its sole Director has approved a second and final liquidating cash distribution (the "Final Liquidating Distribution") in the amount of $0.039251 per share of its outstanding common stock.  The Final Liquidating Distribution will have a record date of December 9, 2010, a payment date of December 16, 2010, and an ex-dividend date of December 17, 2010.  The stock transfer books of the Company will be closed as of December 16, 2010.  The Company will make no further distributions beyond the Final Liquidating Distribution.  There is no requirement for stockholders to surrender shares in connection with the Final Liquidating Distribution.  

An "ex-dividend date" is the date on which a security is traded without a previously declared dividend or distribution.  The timing of the Company's ex-dividend date is determined in accordance with the FINRA rule applicable to such distributions, because the amount of the distribution exceeds 25% of the Company's share value.  Between the record date of December 9, 2010, and the ex-dividend date of December 17, 2010, the stock will trade with due bills reflecting the seller's obligation to transfer the distribution to the buyer.  The due bill redeemable date is December 21, 2010.  

Upon payment of the Final Liquidating Distribution, the Company will have made liquidating distributions (including the first partial liquidating cash distribution made on June 30, 2008, and the Final Liquidating Distribution) in the aggregate amount of $2,990,755, or $0.249251 per share of the Company's common stock.  

Safe Harbor

This press release may contain forward-looking statements within the meaning of the federal securities laws, including statements regarding the timing and amounts available for distributions to holders of the Company's common stock.  Such statements reflect the Company's current expectations with respect to future events and are based on its current assumptions and information currently available.  Actual results may differ materially.  There can be no assurance that the Company's expectations will be achieved.  These forward looking statements are neither promises nor guarantees.  The Company undertakes no responsibility to revise or update and such forward-looking statements.  


'/>"/>
SOURCE Innovative Clinical Solutions, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ActiveHealth Management to Deliver Innovative NuVal™ Nutritional Scoring System Through Health Website
2. Chilean Companies Show Innovative Solutions
3. Top Business School Students From Around the World Compete for Innovative Solutions to the Global Clean Water Crisis
4. FDA Launches Initiative to Develop Innovative External Defibrillators
5. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
6. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
7. New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome
8. CVS Caremark Research Highlights How Innovative Plan Designs Help Clients Reduce Drug Spend and Improve Generic Dispensing Rates
9. Physicians Pharmaceutical Corporation Offers Innovative On-Site Drug Dispensaries
10. Results of Innovative Clinical Study Show New Combination for Weight Loss Success
11. AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... -- The innovator of COMBO ... s first dual therapy stent, introduces catheters for lower ... a global company specializing in the provision of life-changing ... to treat peripheral artery disease. The JADE™ and Scoreflex™ ... lower limb and arteriovenous (AV) fistula intervention. ...
(Date:5/24/2016)... May 24, 2016 Dutch surgeons have launched ... around the world and treat patients on a global scale. Medical ... , Asia and the US have already ... messaging and networking in a totally secure environment. Education  ... war zone working together with a surgeon at Harvard to treat ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Each year ... medicine. Allison Outerbridge is this year’s Life University winner of a ... the university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter ...
(Date:5/26/2016)... ... 26, 2016 , ... Cabot Corporation, Pfizer, and 3M are ... court documents and SEC filings. A jury has returned a verdict of ... Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded $22.8 million ...
(Date:5/26/2016)... ... 2016 , ... The Woodlands at John Knox Village , Florida’s first ... for living and healing, celebrated its grand opening, today. The Woodlands at John Knox ... by Empowered Staff. , “This is an incredibly fulfilling time for John Knox Village ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... the Foundation Fighting Blindness, Long Island Chapter on June 4, 2016, 1:30-3:30 pm ... Dr. Maisel, founder of Retina Group of New York , is a ...
(Date:5/26/2016)... ... May 26, 2016 , ... Eating Recovery Center, Washington ... opening a brand new child and adolescent residential treatment center on June 1. ... even more specialized eating disorder treatment and access to life-saving care. , To ...
Breaking Medicine News(10 mins):